A study on 222 stage I NSCLC patients demonstrated no survival difference associated with TTF1 immunoreactivity (Pelosi et al, 2001), while another study correlated a positive TTF1 staining of resected NSCLC with a poor survival (Puglisi et al, 1999). This evidence concerns the gene TTF1 and non-small cell lung carcinoma.